small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniDiversity, Equity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search

Capabilities 82 results

Industry

Medical Devices

The medical device industry is currently undergoing monumental change—from supply chain challenges to disruptive technologies and economic fluctuations. To pave the way for a more accessible and innovative health care landscape—including advances in wearables, implants, diagnostics, mobility, drug delivery—the evolving and expansive medical device industry faces wide-ranging legal needs. Clients in this sector can tap the remarkable depth and breadth of our sector-focused and skilled attorneys in the U.S. and abroad. Our Health Care & Life Sciences Industry Group engages clients at all points in the product development life cycle to provide sound advice and practical solutions regardless of the client’s size or the complexity of their need. We help clients navigate today’s complex regulatory landscape, defend products and reputations in the face of high-profile product liability and mass tort claims, protect innovative intellectual property (IP), and leverage cross-border experience to advise on commercial transactions....Read more

Industry

Life Sciences

Winston has been a major player in the life sciences industry for decades. We represent market-leading clients across this broad sector, including companies involved in pharmaceuticals, biologics, biosimilars, biotechnology, and medical devices. Our attorneys are seasoned practitioners—many of whom have technical degrees in areas key to the life sciences sector, including biology, chemistry, pharmacy, and biomedical engineering—and bring a unique understanding of the industry and perspective to our representations....Read more

Practice Area

Government Program Fraud, False Claims Act & Qui Tam Litigation

Investigations and litigation involving alleged fraud against the government pose a significant and growing threat to organizations and individuals across all industries that engage directly or indirectly in business with federal, state, and/or local governments. The government makes aggressive use of its extensive criminal and civil investigatory powers to root out alleged fraud and abuse implicating government funds, including one of its most powerful civil enforcement tools—the federal False Claims Act (FCA)—and similar state false claims statutes....Read more

Insights & News 4,859 results

In the Media

|

December 4, 2024

|

Less Than 1 Min Read

Winston Partner to Join Webinar On Consolidated Appropriations Act

On December 4, 2024, Winston Partner Amy Gordon will be participating in a webinar discussing the Consolidated Appropriations Act (CAA).  Amy, along with a team of industry experts, will discuss:...Read more

Speaking Engagement

|

November 25, 2024

Dainia Jabaji Speaks on Sanctions Impacting Palestine and Related Compliance Considerations

On November 25, 2024, of counsel Dainia Jabaji will speak on the webinar “Sanctions 101” hosted by the Palestinian American Bar Association....Read more

Product Liability & Mass Torts Digest

|

November 21, 2024

|

6 Min Read

Proximate Cause with Teeth: Recent Case-Dispositive Expert Exclusions in Product Liability Cases

Under both strict product liability and negligence theories, plaintiffs must establish proximate causation where there is a reasonable certainty that the defendant’s acts caused the injury. Several recent cases have emphasized the Daubert requirement that expert testimony supporting proximate cause for product liability claims must be non-speculative and backed by reliable, reproducible, scientific methodologies.

View All Insights & News

Other Results 108 results

Site Content

The Corporate Transparency Act
Task Force

Site Content

What Is the Securities Act of 1933?

The Securities Act of 1933 (as amended, the “Securities Act”) was passed to ensure that investors have financial and other important information about securities that are being sold publicly. It also bans the use of fraud, deceit, and misrepresentation in the sales of securities. The Securities Act, which is also referred to as the “truth in securities” law, is part of a legislative effort to govern and oversee the securities industry....Read more

Site Content

What Is the JOBS Act?

The Jumpstart Our Business Startups (JOBS) Act is legislation, enacted on April 5, 2012, designed to encourage funding of small businesses in the U.S. by easing securities regulations and therefore making it easier for private companies to access the public capital markets....Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2024. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceEqual Rights AmendmentLaw GlossaryNew Administration: The Transition Period UpdateWinston MinutePrivacy PolicyCookie PolicyNoticesSubscribeAttorney Advertising